Role of N-acetylcysteine in the management of COPD.

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, W A

Sadowska, Anna M; Verbraecken, J; Darquennes, K; De Backer, W A.

Affiliation

Sadowska AM; Department of Pulmonary Medicine, University of Antwerp, Antwerp, Belgium. anna.sadowska@ua.ac.be

Int J Chron Obstruct Pulmon Dis ; 1(4): 425-34, 2006.

Article in En | MEDLINE | ID: mdl-18044098

Subject(s)

Acetylcysteine/therapeutic use; Expectorants/therapeutic use; Lung/physiopathology; Pulmonary Disease, Chronic Obstructive/drug therapy; Acetylcysteine/pharmacology; Cost-Benefit Analysis; Dyspnea/drug therapy; Expectorants/pharmacology; Humans; Lung/drug effects; Quality of Life; Respiratory Function Tests; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylcysteine / Pulmonary Disease, Chronic Obstructive / Expectorants / Lung Aspects: Patient_preference Limits: Humans Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2006 Document type: Article Affiliation country: Belgium Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google